The novelty of cardio-oncology and its associated concepts lends itself to administrative, clinical, research-related and educational challenges that may require attention in the near future as the field continues to advance, according to an article recently published in the Journal of the American College of Cardiology.

Tochi M. Okwuosa, DO, FACC, et al., discuss the challenges that various institutions, ranging from small hospitals to larger academic centers, are tackling, such as disputes over the name, billing, ownership, patient population, training, funding and more.

“As the growing population of cancer survivors age, the cardiac side effects of therapy can be expected to compile with common comorbidities,” the authors write. “Attention to [these] issues will ensure the stability and readiness of this important specialty of cardio-oncology to tackle the needs of this distinctive population.” Read more.